Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Qaradakhi T, Gadanec LK, McSweeney KR, Tacey A, Apostolopoulos V, Levinger I, Rimarova K, Egom EE, Rodrigo L, Kruzliak P, Kubatka P, Zulli A. Qaradakhi T, et al. Among authors: egom ee. Clin Exp Pharmacol Physiol. 2020 May;47(5):751-758. doi: 10.1111/1440-1681.13251. Epub 2020 Jan 28. Clin Exp Pharmacol Physiol. 2020. PMID: 31901211 Review.
The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure.
Caprnda M, Zulli A, Shiwani HA, Kubatka P, Filipova S, Valentova V, Gazdikova K, Mozos I, Berukstis A, Laucevicius A, Rihacek I, Dragasek J, Prosecky R, Egom EE, Staffa R, Kruzliak P, Krasnik V. Caprnda M, et al. Among authors: egom ee. Clin Exp Pharmacol Physiol. 2020 Jul;47(7):1120-1133. doi: 10.1111/1440-1681.13290. Epub 2020 Mar 20. Clin Exp Pharmacol Physiol. 2020. PMID: 32083749 Review.
Mechanisms of renal hyporesponsiveness to BNP in heart failure.
Egom EE, Feridooni T, Hotchkiss A, Kruzliak P, Pasumarthi KB. Egom EE, et al. Can J Physiol Pharmacol. 2015 Jun;93(6):399-403. doi: 10.1139/cjpp-2014-0356. Epub 2015 Feb 26. Can J Physiol Pharmacol. 2015. PMID: 25881664 Review.
Markers of Atherosclerosis: Part 2 - Genetic and Imaging Markers.
Tibaut M, Caprnda M, Kubatka P, Sinkovič A, Valentova V, Filipova S, Gazdikova K, Gaspar L, Mozos I, Egom EE, Rodrigo L, Kruzliak P, Petrovic D. Tibaut M, et al. Among authors: egom ee. Heart Lung Circ. 2019 May;28(5):678-689. doi: 10.1016/j.hlc.2018.09.006. Epub 2018 Sep 29. Heart Lung Circ. 2019. PMID: 30318392 Review.
Markers of Atherosclerosis: Part 1 - Serological Markers.
Tibaut M, Caprnda M, Kubatka P, Sinkovič A, Valentova V, Filipova S, Gazdikova K, Gaspar L, Mozos I, Egom EE, Rodrigo L, Kruzliak P, Petrovic D. Tibaut M, et al. Among authors: egom ee. Heart Lung Circ. 2019 May;28(5):667-677. doi: 10.1016/j.hlc.2018.06.1057. Epub 2018 Oct 4. Heart Lung Circ. 2019. PMID: 30468147 Review.
Latest Updates on Lipid Management.
Egom EE, Pharithi RB, Hesse S, Starr N, Armstrong R, Sulaiman HM, Gazdikova K, Mozos I, Caprnda M, Kubatka P, Kruzliak P, Khan B, Gaspar L, Maher VMG. Egom EE, et al. High Blood Press Cardiovasc Prev. 2019 Apr;26(2):85-100. doi: 10.1007/s40292-019-00306-8. Epub 2019 Mar 15. High Blood Press Cardiovasc Prev. 2019. PMID: 30877603 Review.
Is there a way out for the 2014 Ebola outbreak in Western Africa?
Andreas A, Binoun A Egom C, Kruzliak P, Egom EE. Andreas A, et al. Among authors: egom ee. Asian Pac J Trop Med. 2015 Oct;8(10):773-8. doi: 10.1016/j.apjtm.2015.09.001. Epub 2015 Sep 25. Asian Pac J Trop Med. 2015. PMID: 26522290 Free article. Review.
59 results